These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32775329)

  • 1. β-Blocker Doses and Heart Rate in Patients with Heart Failure: Results from the National Norwegian Heart Failure Registry.
    Eriksen-Volnes T; Westheim A; Gullestad L; Slind EK; Grundtvig M
    Biomed Hub; 2020; 5(1):9-18. PubMed ID: 32775329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
    Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate control and its predictors in patients with heart failure and sinus rhythm. Data from the European Society of Cardiology Long-Term Registry.
    Tymińska A; Ozierański K; Wawrzacz M; Balsam P; Maciejewski C; Kleszczewska M; Zawadzka M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Opolski G; Grabowski M; Kapłon-Cieślicka A
    Cardiol J; 2022 Aug; 30(6):964-73. PubMed ID: 35975794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed?
    Franke J; Wolter JS; Meme L; Keppler J; Tschierschke R; Katus HA; Zugck C
    Clin Res Cardiol; 2013 Jan; 102(1):23-31. PubMed ID: 22760479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study).
    Fu M; Ahrenmark U; Berglund S; Lindholm CJ; Lehto A; Broberg AM; Tasevska-Dinevska G; Wikstrom G; Ågard A; Andersson B;
    Clin Res Cardiol; 2017 Dec; 106(12):960-973. PubMed ID: 28795299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta-blockers.
    Varian KD; Ji X; Grodin JL; Verbrugge FH; Milinovich A; Kattan MW; Tang WHW
    ESC Heart Fail; 2020 Oct; 7(5):3049-3058. PubMed ID: 32757485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resting heart rate and real-life treatment modalities in outpatients with left ventricular systolic dysfunction study: A multicenter, prospective, observational, and national registry.
    Çavuşoğlu Y; Kozan Ö; Temizhan A; Küçükoğlu MS
    Anatol J Cardiol; 2021 May; 25(5):304-312. PubMed ID: 33960305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Current Drug Therapy for Heart Failure Sufficient to Control Heart Rate of Patients?
    Cardoso J; Espíndola MD; Cunha M; Netto E; Cardoso C; Novaes M; Del Carlo CH; Brancalhão E; Name AL; Barretto ACP
    Arq Bras Cardiol; 2020 Dec; 115(6):1063-1069. PubMed ID: 33470302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
    Barywani S; Petzold M
    Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
    Böhm M; Abdin A; Slawik J; Mahfoud F; Borer J; Ford I; Swedberg K; Tavazzi L; Batailler C; Komajda M
    Eur J Heart Fail; 2023 Aug; 25(8):1429-1435. PubMed ID: 37092340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
    Owens RE; Twilla JD; Self TH; Alshaya AI; Metra CJ; Cummings C; Oliphant CS
    J Pharm Pract; 2018 Feb; 31(1):40-45. PubMed ID: 28737066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate reduction and exercise performance in recent onset heart failure with reduced ejection fraction: arguments for beta-blocker hypo-response.
    Verbrugge FH; Vrijsen J; Vercammen J; Grieten L; Dupont M; Mullens W
    Acta Cardiol; 2015 Oct; 70(5):565-72. PubMed ID: 26567816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction.
    Li S; Li X
    High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):405-411. PubMed ID: 31625118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Characteristics and Outcomes of Patients with Heart Failure and Reduced Ejection Fraction: The Eligibility of Novel Heart Failure Medications.
    Fong MC; Chang HY; Wang CC; Feng AN; Lin WS; Wu YW; Sung SH; Huang JL; Kuo JY; Yin WH
    Acta Cardiol Sin; 2021 Jul; 37(4):394-403. PubMed ID: 34257489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential prognostic impact of resting heart rate in older compared with younger patients with chronic heart failure--insights from TIME-CHF.
    Zurek M; Maeder MT; Rickli H; Muzzarelli S; Sanders-van Wijk S; Abbühl H; Handschin R; Jeker U; Pfisterer M; Brunner-la Rocca HP;
    J Card Fail; 2015 Apr; 21(4):347-54. PubMed ID: 25576682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
    Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
    J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.